FDA Advisory Panel Recommends Pfizer COVID-19 Vaccine For Approval
On Thursday, the Food and Drug Administration’s regulatory vaccines committee voted to recommend the COVID-19 vaccine developed by Pfizer and BioNTech for emergency use authorization. The vote by the FDA Vaccines and Related Biological Products Advisory Committee